Omegaven

Omegaven, the active ingredient in Omegaven, is a lipid emulsion presented as a 10% (v/v) intravenous emulsion for parenteral use. It supplies essential omega‑3 fatty acids and is employed in patients requiring parenteral nutrition, particularly those with intestinal failure or parenteral nutrition‑associated liver disease.

GNH USA supplies Omegaven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Omegaven is used in parenteral nutrition to address lipid deficiencies and related liver complications.

- Intestinal failure: provides essential fatty acids when enteral feeding is not possible. - Parenteral nutrition‑associated liver disease: helps reduce hepatic inflammation and steatosis. - Severe malabsorption syndromes: supplies omega‑3 fatty acids to support growth and immune function. - Pediatric patients requiring fish‑oil based lipid support: offers a safer lipid profile for infants and children.

Common Side Effects: - Hypertriglyceridemia: elevated blood triglyceride levels. - Fat overload syndrome: excessive lipid accumulation. - Fever or chills during infusion. - Infusion site erythema or pain. - Thrombocytopenia: reduced platelet count. - Mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Fat embolism syndrome. - Coagulopathy or bleeding complications. - Severe hepatic dysfunction. - Infection related to lipid emulsion contamination. - Metabolic acidosis.

Before initiating Omegaven therapy, consider the following precautions.

- Monitor triglycerides: check serum levels regularly to avoid hypertriglyceridemia. - Assess liver function: evaluate hepatic enzymes and bilirubin during treatment. - Check coagulation status: watch for bleeding tendencies, especially with anticoagulants. - Avoid in known fish or egg allergy: contraindicated for patients with hypersensitivity to these components. - Do not combine with other lipid emulsions unless medically justified. - Store below 25°C: keep in the original container, protect from light and moisture.

Omegaven may interact with other medications or nutrients.

Major Interactions (Avoid): - Warfarin or other anticoagulants: may enhance anticoagulant effect and increase bleeding risk. - Other intravenous lipid emulsions: concurrent use can cause fat overload. - High‑dose vitamin E supplements: may increase risk of bleeding.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., cyclosporine): may alter drug levels. - Parenteral nutrition components containing high calcium or phosphate: monitor for precipitation. - Certain antibiotics administered via the same line: assess compatibility before co‑infusion.